Monte Rosa Therapeutics, Inc. (GLUE): Dividends Paid

Annual figures by period end, from SEC filings.

Year ended 2025-12-31

Trailing 12 months to 2026-06-30

Period ended	Dividends Paid	Change YoY	Source filing
2025-12-31	$0	n/a	2026-03-17, From 2025-01-01
2024-12-31	$0	n/a	2025-03-20, From 2024-01-01
2023-12-31	$0	n/a	2024-03-14, From 2023-01-01
2022-12-31	$0	n/a	2023-03-16, From 2022-01-01
2021-12-31	$0	n/a	2022-03-29, From 2021-01-01

Dividends Paid at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Dividends Paid	Change YoY
Monte Rosa Therapeutics, Inc. (GLUE)	2025-12-31	$0	n/a
Scilex Holding Co (SCLX)	2024-12-31	$8.65M	0.0%
Bio-Techne Corp (TECH)	2026-06-30	$49.92M	-0.9%
Qiagen N.V. (QGEN)	2025-12-31	$54.24M	n/a
Gilead Sciences, Inc. (GILD)	2025-12-31	$4.00B	+2.2%
Amgen Inc (AMGN)	2025-12-31	$5.12B	+6.0%
Viskase Holdings, Inc. (VISK)	2025-12-31	$1.27M	0.0%
Windtree Therapeutics Inc (WINT)	2024-12-31	$657.0K	n/a
Vor Biopharma Inc. (VOR)	2025-12-31	$0	n/a

Compare GLUE, SCLX, TECH, QGEN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗